Agilysys (AGYS) Cash & Equivalents (2010 - 2026)

Agilysys (AGYS) has 17 years of Cash & Equivalents data on file, last reported at $116.9 million in Q1 2026.

• On a quarterly basis, Cash & Equivalents rose 60.04% year-over-year to $116.9 million in Q1 2026; TTM through Mar 2026 was $116.9 million, a 60.04% increase from a year earlier, with the FY2026 full-year figure at $116.9 million, up 60.04% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $116.9 million, up from $81.5 million in the prior quarter.
• Over the last five years, Cash & Equivalents for AGYS reached as high as $144.9 million in Q1 2024 and fell as low as $54.9 million in Q3 2024.
• Historically, Cash & Equivalents has averaged $95.8 million across 5 years, with a median of $97.0 million in 2022.
• Across the five-year window, Cash & Equivalents tumbled 61.44% in 2025 and jumped 60.04% in 2026, its largest moves.
• Year by year, Cash & Equivalents stood at $105.8 million in 2022, then rose by 9.81% to $116.2 million in 2023, then slumped by 47.71% to $60.8 million in 2024, then jumped by 34.05% to $81.5 million in 2025, then jumped by 43.51% to $116.9 million in 2026.
• Per Business Quant data, the three most recent Cash & Equivalents figures were $116.9 million in Q1 2026, $81.5 million in Q4 2025, and $59.3 million in Q3 2025.